Arrowhead Research reported $-81170000 in EBITDA for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Agios Pharmaceuticals AGIO:US USD -89109000 6.24M
Alnylam Pharmaceuticals ALNY:US USD -247440000 65.85M
Arrowhead Research ARWR:US USD -81170000 10.86M
Bluebird Bio BLUE:US USD -85093000 14.32M
Intercept Pharmaceuticals ICPT:US USD -10064000 808K
Mirati Therapeutics MRTX:US USD -185727000 9.22M
Moderna Inc MRNA:US USD 1.28B 1.24B
Nektar Therapeutics NKTR:US USD -34794000 9.48M
Novartis NOVN:VX USD 4.69B 34M
Sarepta Therapeutics SRPT:US USD -120652000 80.59M
Tg Therapeutics TGTX:US USD -34887000 3.98M
Ultragenyx Pharmaceutical RARE:US USD -220372000 83.26M
Vertex Pharmaceuticals VRTX:US USD 1.16B 6.8M
Xencor XNCR:US USD -36110000 10.33M
YTE INCY:US USD 134.94M 141.85M